📰 Peter Openshaw News
Page 3 - Peter Openshaw News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Openshaw. Real-time updates on events, politics, business and more.
June 18, 2024
Hello, youre watching afternoon live im simon mccoy. Today at two full steam ahead for hsz. The Prime Minister confirms that the whole of the High Speed Rail plan will go ahead, with the first trains running by the end of the decade. The cabinet has given High Speed Rail the green signal. We are going to get this done. Ill be reporting live from the h52 construction site here in birmingham and getting reaction to the Prime Ministers announcement from the mayor of the West Midlands. The british b...
June 13, 2024
Study finds that antibodies from people with the debilitating condition trigger similar symptoms in mice. Study finds that antibodies from people with the debilitating condition trigger similar symptoms in mice.
April 10, 2024
Imperial College London-led research sheds light on what is causing Long Covid symptoms as scientists insist 'people aren't imagining this'
April 9, 2024
Long COVID leaves distinctive signs in the blood which could potentially be targeted for treatment, research suggests. Findings from the largest UK st...
April 8, 2024
Gibraltar News, GBC News, Latest Gibraltar News
April 8, 2024
The UK's largest study of Covid patients treated in hospital found signs of active inflammation.
April 8, 2024
An official inquiry has opened into allegations that Gibraltar’s most senior policeman was forced to leave the force after investigating alleged government fraud.
April 8, 2024
Long Covid symptoms may be driven by the reactivation of dormant viruses such as herpes, scientists have suggested, after finding evidence of inflammation in the blood of sufferers.
April 8, 2024
The findings suggest existing drugs could be helpful in treating long Covid and should be investigated.
April 8, 2024
People with long covid after a serious covid-19 infection have raised levels of many immune molecules in their blood. Better understanding how these molecules can vary could lead to more targeted treatments